Literature DB >> 1735151

Migratory activity of human smooth muscle cells cultivated from coronary and peripheral primary and restenotic lesions removed by percutaneous atherectomy.

G Bauriedel1, U Windstetter, S J DeMaio, R Kandolf, B Höfling.   

Abstract

BACKGROUND: The successful cultivation of human smooth muscle cells (SMC) from coronary and peripheral atherosclerotic lesions removed by percutaneous directional atherectomy is described. METHODS AND
RESULTS: Sixty-seven patients in whom plaque material was obtained compose the study population. A total of 73 lesions from both coronary (n = 38) and peripheral (n = 35) arteries of primary (n = 50) and restenotic origin (n = 23) were studied. Successful cultivation was significantly (p less than 0.001) dependent on the quantity of plaque material submitted. Fifty-five percent of patients in whom atherectomy specimens were removed from coronary lesions yielded an adequate SMC population in comparison to 89% of those from peripheral arteries (p less than 0.01). Cultivation was not dependent on the age and sex of patients, lesion origin, risk factors, medications, or incidence of unstable angina. In an attempt to quantify SMC activity, migratory velocity was measured with a computer-assisted motion analysis system. SMC migratory velocity was found to be significantly (p less than 0.001) greater in restenotic than in primary plaque material. This finding was confirmed for both coronary and peripheral lesions.
CONCLUSIONS: Our data suggest that elevated SMC migratory activity may be an important mechanism in the development of restenotic lesions.

Entities:  

Mesh:

Year:  1992        PMID: 1735151     DOI: 10.1161/01.cir.85.2.554

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Re: Histological analysis of atherectomy specimens: an opportunity neglected to guide therapy preventing restenosis.

Authors:  X Yang; H Manninen; S Soimakallio
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Mar-Apr       Impact factor: 2.740

3.  Therapeutic approaches to the control of fibrocellular intimal hyperplasia after angioplasty.

Authors:  J McEwan
Journal:  Br Heart J       Date:  1993-07

4.  Experimental study on the effect of ligustrazine in the prevention of intimal proliferation of deendothelial artery.

Authors:  X Zhou; Z Lu; H Zhao; D Wang
Journal:  J Tongji Med Univ       Date:  2000

5.  Effects of captopril on platelet cytosolic free Ca2+ concentrations and on suppression of cell proliferation in culture.

Authors:  D W Wang; H Y Zhao; S L Yang; Z D Deng
Journal:  J Tongji Med Univ       Date:  1993

6.  Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma.

Authors:  Randolph Hutter; Li Huang; Walter S Speidl; Chiara Giannarelli; Paul Trubin; Gerhard Bauriedel; Mary E Klotman; Valentin Fuster; Juan J Badimon; Paul E Klotman
Journal:  Circulation       Date:  2013-09-16       Impact factor: 29.690

7.  Experimental studies on prevention of atherosclerotic arterial stenosis and restenosis after angioplasty with Andrographis Paniculata Nees and fish oil.

Authors:  D W Wang; H Y Zhao
Journal:  J Tongji Med Univ       Date:  1993

8.  Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity.

Authors:  L M Rasmussen; Y G Wolf; E Ruoslahti
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

9.  Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio.

Authors:  Rainer Voisard; Mustafa Alan; Lutz von Müller; Regine Baur; Vinzenz Hombach
Journal:  BMC Cardiovasc Disord       Date:  2006-04-04       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.